Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1

Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1

US Patent 6022711 · Granted Feb 8, 2000

Estimated economic value: $154,077,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Compositions and methods for conjugating activatable antibodies2024
Antibody chemically induced dimerizer (AbCID) as molecular switches for regulati2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Antibodies against CDCP1 for the treatment and detection of cancer2023
Method of treating or delaying progression of an epidermal growth factor recepto2021
Multispecific antibodies, multispecific activatable antibodies and methods of us2021
Engineered antibodies for the detection of phosphorylated tyrosine2021
Cyclic peroxides as prodrugs for selective delivery of agents2021
Activatable antibodies having non-binding steric moieties and methods of using t2021
Activatable antibodies that bind epidermal growth factor receptor and methods of2020